New vaccines herald “era-defining advancements” in RSV prevention
The landscape of respiratory syncytial virus (RSV) in Australia has rapidly evolved, thanks to new vaccines and a rollout of state and national immunisation programs.
News
Medical journals of the world unite to demand action on nuclear weapons
The Medical Journal of Australia joins with medical journals around the world to call for the re-establishment of the World Health Organization’s mandate on addressing the health consequences of nuclear weapons and war.
Supporting adolescent wellbeing in the digital age
Adolescents must be involved in the development of digital health care initiatives if they are to be engaging and effective.
Gestational diabetes soars by 70% in Australia: what’s driving the surge?
Gestational diabetes mellitus (GDM) prevalence has surged by almost 70% in five years, putting thousands of women and their babies at risk of future health complications. Of particular concern is the Northern Territory, which has almost tripled its incidence of GDM, while Victoria has doubled its incidence.
Celebrating 40 Years of Impact: The Menzies Collection
As Menzies School of Health Research (Menzies) marks its 40th anniversary in 2025, the release of the Menzies Collection in the Medical Journal of Australia provides a timely reflection on four decades of impactful health research across northern Australia and the Asia–Pacific, particularly in Aboriginal and Torres Strait Islander health.
Deepfake technology exploited a well known endocrinologist’s trust and authority. Can the industry avoid deepfakes?
Late last year, an AI-generated video faked the image of a well known endocrinologist and spread dangerous medical advice on Facebook. InSight+ spoke to industry professionals about the effect these fakes have on health and trust.
Re-evaluating antidepressant prescribing in primary care
Antidepressants are being overprescribed, but there is limited guidance for general practitioners or their patients when it comes to stopping the medication.
New Cochrane review weighs up the latest evidence on stem cell injections for osteoarthritis
A new Cochrane review examines the latest evidence on stem cell injections for knee osteoarthritis — a debilitating condition that affects over 2 million Australians and costs the health system more than $4 billion each year. The findings highlight how much uncertainty remains around the potential benefits of this increasingly popular treatment option.
New guidelines for osteoporosis management
The updated guidelines for osteoporosis management and fracture prevention are an evidence‐based pragmatic tool designed to support general practitioners in the treatment and management of at-risk patients.
